Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Tax Provisions (2019 - 2025)

CorMedix's Tax Provisions history spans 7 years, with the latest figure at $68.2 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 29662402.17% year-over-year to $68.2 million; the TTM value through Dec 2025 reached $12.2 million, up 977.53%, while the annual FY2025 figure was $12.8 million, 1014.55% up from the prior year.
  • Tax Provisions for Q4 2025 was $68.2 million at CorMedix, up from -$56.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $68.2 million in Q4 2025 and bottomed at -$56.0 million in Q3 2025.
  • The 4-year median for Tax Provisions is -$5230.0 (2024), against an average of $1.2 million.
  • The largest YoY upside for Tax Provisions was 29662402.17% in 2025 against a maximum downside of 1070593.35% in 2025.
  • A 4-year view of Tax Provisions shows it stood at $1.9 million in 2021, then crashed by 131.21% to -$585617.0 in 2022, then soared by 99.96% to -$230.0 in 2024, then soared by 29662402.17% to $68.2 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Tax Provisions are $68.2 million (Q4 2025), -$56.0 million (Q3 2025), and -$230.0 (Q4 2024).